MDT
88.65
+1.69%↑
VEEV
282.96
-1.55%↓
A
120.24
+1.92%↑
HQY
102.79
-1.67%↓
PHR.US
28.46
+0.21%↑
MDT
88.65
+1.69%↑
VEEV
282.96
-1.55%↓
A
120.24
+1.92%↑
HQY
102.79
-1.67%↓
PHR.US
28.46
+0.21%↑
MDT
88.65
+1.69%↑
VEEV
282.96
-1.55%↓
A
120.24
+1.92%↑
HQY
102.79
-1.67%↓
PHR.US
28.46
+0.21%↑
MDT
88.65
+1.69%↑
VEEV
282.96
-1.55%↓
A
120.24
+1.92%↑
HQY
102.79
-1.67%↓
PHR.US
28.46
+0.21%↑
MDT
88.65
+1.69%↑
VEEV
282.96
-1.55%↓
A
120.24
+1.92%↑
HQY
102.79
-1.67%↓
PHR.US
28.46
+0.21%↑
24h
Current
Min
3.15
Max
3.41
Income | 522K -2.9M |
---|---|
Sales | -1.7M 3.4M |
EPS | -0.12 |
Profit margin | -85.659 |
Employees | 61 |
EBITDA | -484K -3.4M |
Recommendations | Buy |
---|---|
12 Months Forecast | +1039.82% upside |
Market Cap | 6.7M |
---|---|
Previous open | 0.21 |
Previous close | 3.32 |
By Trading Central
Confidence
Bearish Evidence
0.4084 / 0.4998 Support & Resistance
Past performance is not a reliable indicator of future results.
1 Jul 2025, 23:09 UTC
Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update
DJ
Read
1 Jul 2025, 19:16 UTC
Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander
DJ
Read
1 Jul 2025, 23:47 UTC
Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk
DJ
Read
1 Jul 2025, 23:41 UTC
Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk
DJ
Read
1 Jul 2025, 22:23 UTC
James Hardie: Deal Represents Implied Value of $8.4 Billion
DJ
Read
1 Jul 2025, 22:23 UTC
James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share
DJ
Read
1 Jul 2025, 22:21 UTC
James Hardie Completes Acquisition of AZEK
DJ
Read
1 Jul 2025, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Read
1 Jul 2025, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
1 Jul 2025, 20:24 UTC
Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com
DJ
Read
1 Jul 2025, 19:55 UTC
Oil Futures Resume Cautious Rally -- Market Talk
DJ
Read
1 Jul 2025, 19:27 UTC
U.S. Natural Gas Futures Lose More Ground -- Market Talk
DJ
Read
1 Jul 2025, 19:12 UTC
Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk
DJ
Read
1 Jul 2025, 19:01 UTC
Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander
DJ
Read
1 Jul 2025, 18:41 UTC
How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com
DJ
Read
1 Jul 2025, 18:33 UTC
Market Talk Roundup: Latest on U.S. Politics
DJ
Read
1 Jul 2025, 18:33 UTC
Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk
DJ
Read
1 Jul 2025, 18:32 UTC
Mexico Manufacturing PMIs Remain Weak in June -- Market Talk
DJ
Read
1 Jul 2025, 18:22 UTC
Remittances to Mexico Down in May -- Market Talk
DJ
Read
1 Jul 2025, 17:45 UTC
Seasonal Demand Supports Further Oil Gains -- Market Talk
DJ
Read
1 Jul 2025, 17:01 UTC
Danone Completed Acquisition of Majority Stake in Kate Farms
DJ
Read
1 Jul 2025, 16:55 UTC
10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com
DJ
Read
1 Jul 2025, 16:27 UTC
Trade Concerns Ease in Bank of Mexico Survey -- Market Talk
DJ
Read
1 Jul 2025, 16:25 UTC
Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk
DJ
Read
1 Jul 2025, 16:20 UTC
Health Care Roundup: Market Talk
DJ
Read
1 Jul 2025, 15:48 UTC
Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk
DJ
Read
1 Jul 2025, 15:46 UTC
Global Equities Roundup: Market Talk
DJ
Read
1 Jul 2025, 15:46 UTC
Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk
DJ
Read
1 Jul 2025, 14:54 UTC
Thales Expected to Stick to This Year's Sales Guidance -- Market Talk
DJ
Read
1 Jul 2025, 14:49 UTC
Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 37.5 USD 1039.82%
High 60 USD
Low 15 USD
Based on 2 Wall Street analysts offering 12 month price targets forEkso Bionics Holdings - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Ekso Bionics Holdings - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
No Evidence
There are no events.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$